Etevritamab Antibody is a research-grade biosimilar monoclonal antibody targeting CD3. Reactivity: Human. Supplied as a liquid in 30 mM Histidine, pH5.8, 10% sucrose, 0.02% Tween80. Applications: ELISA, flow cytometry, functional assays and in vivo research. Endotoxin: < 10 EU/mg. Purity: >95% purity as determined by SDS-PAGE. For research use only.
Etevritamab is an anti-CD3E/EGFR monoclonal antibody.